Liquid Biopsy Market to Grow at a CAGR of 32.2% to reach US$ 358.91 Million from 2020 to 2027

Liquid Biopsy Market Forecast to 2027 - Covid-19 Impact and Global Analysis by Product and Services (Equipment, Reagents & Kits, and Services); Sample (Blood Based, Urine Based, and Other samples); Circulating Biomarker (Circulating Tumor Cells (CTC), Exosomes, and Free Nucleic Acid); Application (Noninvasive Prenatal Testing (NIPT), Oncology, Transplant Diagnostics, and Other Applications); End User (Academic & Research Institutes, Hospitals, Reference Laboratories, and Other End Users), and Geography

Publication Month: Apr 2020 | Report Code: TIPRE00003996 | No. of Pages: 195 | Category: Medical Device | Status: Published
Covid

The liquid biopsy market was valued at US$ 3,861.49 million in 2019and is projected to reach US$ 8,123.85 million by 2027; it is expected to grow at a CAGR of 9.9% during 2020–2027.

 

Liquid biopsy is a revolutionary technology that is opening up various perspectives. The technology consists of isolation and detection of circulating tumor cells, tumor DNA and exosomes, which provides genomic information of the cancer patients. Liquid biopsy is used in cancer diagnosis in order to study the response or resistance to given treatments.Different samples used for liquid biopsy are blood, urine, and other samples which includes stool and others. Additionally, circulating tumor cells (ctc), exosomes, and free nucleic acid are the circulating biomarkers used for detection of cancers.

 

Lucrative Regional Liquid Biopsy Markets

Lucrative Regional Liquid Biopsy Markets

Get more information on this report :


 

Market Insights

Government and Global Health Organizations Initiatives

The liquid biopsy test is conducted to detect cancer at an early stage. The test is performed either on a blood sample to identify cancer cells present in the in blood stream, or on the DNA extracted from tumor cells. The government for early detection of cancer takes various initiatives. For instance, the National Institutes of Health (NIH) started a new initiative called Precompetitive Collaboration on liquid biopsy for early cancer assessment. The purposes of this initiative are to establish a Public-Private Partnership Program for the development of new or validate existing technologies, methods, and assays for the capture and quantification of tumor-associated cells, RNA, DNA, or exosomes in body fluids of patients with an early-stage disease or those at high risk. This initiative emphasis early cancer detection by distinguishing aggressive and  nonaggressive cancers, and differentiates benign disease from cancer.

 

The NCI'scommitment of funds towards R&D of clinical advanced technology will encourage the investigators to expand their research for early detection of cancer and accelerate clinical adoption of these promising technologies.

In China and the US, the central government and biotech investors have been financing lung cancer screening by investing in Research & Development and complementary or improved screening tools and diagnostics, such as biomarkers and liquid biopsies.

 

Product and Services Insights

Based on product and services the liquid biopsy market is segmented into equipment, reagents & kits and services. The reagents & kits segment held the largest share of the market in 2019 and the same segment is anticipated to register the highest CAGR in the market during the forecast period.

 

Global Liquid Biopsy Market, by Product and Services – 2019& 2027

Global Liquid Biopsy Market, by Product and Services – 2019& 2027

Get more information on this report :


 

Sample Insights

Based on sample, the liquid biopsy market is segmented into blood based, urine based, and other samples. The blood basedsegment held the largest share of the market in 2019 and is estimated to register the highest CAGR in the market during the forecast period owing to its remarkable advantages over the conventional method.

 

Circulating Biomarker Insights

Based on circulating biomarker, the liquid biopsy market is segmented into circulating tumor cells (CTC), exosomes, and free nucleic acid. The circulating tumor cells (CTC) segment held the largest share of the market in 2019 and is estimated to register the highest CAGR in the market during the forecast period. Factors helping to remain CTC market dominate are advantages over traditional tissue biopsies, as they are non-invasive, can be used repeatedly, and provide more useful information on cancerous cell risk, disease progression, and treatment

 

Applications Insights

Based on application, the liquid biopsy market has been segmented into noninvasive prenatal testing (NIPT), oncology, transplant diagnostics, and other applications. The oncology segment held the largest share of the market in 2019; however, noninvasive prenatal testing (NIPT) segment is estimated to register the highest CAGR in the market during the forecast period.

 

End-UserInsights

Based on end user, the liquid biopsy market has been segmented into academic & research institutes, hospitals, reference laboratories, and other end users. The hospitals segment held the largest share of the market in 2019 and is estimated to register the highest CAGR in the market during the forecast period.

 

Strategic Insights

Product launches and approval strategies are commonly adopted by companies to expand their footprint worldwide and meet the growing demand.

 

The market players operating in the liquid biopsy market adopt the business expansion to enlarge customer base across the world, collaborations, and product launches. These strategies permit the players to maintain their brand name globally. For instance, in August 2018, Exact Sciences Corp. announced signing of partnership with Pfizer to promote Colorguard in the US. Pfizer has helped with sales representative to promote the test to physicians and health systems during marketing campaign.

 

Liquid Biopsy Market - By Product & Service

  • Equipment
  • Reagents & Kits
  • Services


Liquid Biopsy Market - By Sample

  • Blood Based
  • Urine Based
  • Other samples


Liquid Biopsy Market - By Circulating Biomarker

  • Circulating Tumor Cells (CTC)
  • Exosomes
  • Free Nucleic Acid


Liquid Biopsy Market - By Application

  • Noninvasive Prenatal Testing (NIPT)
  • Oncology
  • Transplant Diagnostics
  • Other Applications


Liquid Biopsy Market - By End User

  • Academic & Research Institutes
  • Hospitals
  • Reference Laboratories
  • Other End Users


Liquid Biopsy Market - By Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • UK
    • Spain
    • Rest of Europe
  • Asia Pacific (APAC)
    • China
    • India
    • South Korea
    • Japan
    • Australia
    • Rest of Asia Pacific
  • Middle East & Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Rest of Middle East and Africa
  • South America
    • Brazil
    • Argentina
    • Rest of South America

 

Company Profiles

  • Biocept, Inc
  • Bio-Rad Laboratories Inc
  • LungLife AI, Inc
  • Exosome Diagnostics
  • F. Hoffmann-la Roche ltd
  • Exact Sciences Corporation
  • Inivata Ltd
  • MDxHealth
  • Qiagen
  • Thermo Fisher Scientific Inc.

1.             Introduction

1.1       Scope of the Study

1.2       The Insight Partners Research Report Guidance

1.3       Market Segmentation

1.3.1        Global Liquid Biopsy Market – By Product & Service

1.3.2        Global Liquid Biopsy Market – By Sample

1.3.3        Global Liquid Biopsy Market – By Circulating Biomarker

1.3.4        Global Liquid Biopsy Market – By Application

1.3.5        Global Liquid Biopsy Market – By End User

1.3.6        Global Liquid Biopsy Market – By Geography

2.             Liquid Biopsy Market – Key Takeaways

3.             Research Methodology

3.1       Coverage

3.2       Secondary Research

3.3       Primary Research

4.             Liquid Biopsy – Market Landscape

4.1       Overview

4.2       PEST Analysis

4.2.1        North America – PEST Analysis

4.2.2        Europe – PEST Analysis

4.2.3        Asia Pacific – PEST Analysis

4.2.4        Middle East and Africa (MEA) – PEST Analysis

4.2.5        South and Central America – PEST Analysis

4.3       Expert Opinion

5.             Liquid biopsy– Key Market Dynamics

5.1       Key Market Drivers

5.1.1        Increasing Prevalence of Cancer

5.1.2        Government and Global Health Organizations Initiatives

5.2       Key Market Restraints

5.2.1        Low Sensitivity of Liquid Biopsy

5.3       Key Market Opportunities

5.3.1        Increasing Liquid Biopsy Due to Growing Application and Advancements

5.4       Future Trends

5.4.1        Consistent Launch of New Products

5.5       Impact Analysis

6.             Liquid Biopsy Market – Global Analysis

6.1       Global Liquid Biopsy Market Revenue Forecast and Analysis

6.2       Global Liquid biopsy Market, By Geography - Forecast and Analysis

6.3       Market Positioning of Key Players

7.             Liquid Biopsy Market Analysis – By Product & Services

7.1       Overview

7.2       Liquid Biopsy Market Revenue Share, by Product& Service (2019 and 2027)

7.3       Equipment

7.3.1        Overview

7.4       Equipment: Liquid Biopsy Market – Revenue and Forecast to 2027 (US$ Million)

7.5       Reagents & Kits

7.5.1        Overview

7.5.2        Reagents & Kits: Liquid Biopsy Market – Revenue and Forecast to 2027 (US$ Million)

7.6       Services

7.6.1        Overview

7.6.2        Services: Liquid Biopsy Market – Revenue and Forecast to 2027 (US$ Million)

8.             Liquid Biopsy Market Analysis – By Sample

8.1       Overview

8.2       Liquid Biopsy Market, by Sample, 2019 and 2027 (%)

8.3       Blood Based

8.3.1        Overview

8.3.2        Blood Based: Liquid Biopsy Market – Revenue and Forecast to 2027 (US$ Million)

8.4       Urine Based

8.4.1        Overview

8.4.2        Urine Based: Liquid Biopsy Market – Revenue and Forecast to 2027 (US$ Million)

8.5       Other Samples

8.5.1        Overview

8.6       Other Samples: Liquid Biopsy Market – Revenue and Forecast to 2027 (US$ Million)

9.             Liquid Biopsy Market Analysis – By Circulating Biomarker

9.1       Overview

9.2       Liquid Biopsy Market, by Circulating Biomarker, 2019 and 2027 (%)

9.3       Circulating Tumor Cells (CTC)

9.3.1        Overview

9.3.2        Circulating Tumor Cell (CTC): Liquid Biopsy Market – Revenue and Forecast to 2027 (US$ Million)

9.4       Exosomes

9.4.1        Overview

9.4.2        Exosomes: Liquid Biopsy Market – Revenue and Forecast to 2027 (US$ Million)

9.5       Free Nucleic Acid

9.5.1        Overview

9.5.2        Free Nucleic Acid: Liquid Biopsy Market – Revenue and Forecast to 2027 (US$ Million)

10.          Liquid Biopsy Market Analysis – By Application

10.1    Overview

10.2    Liquid Biopsy Market, by Application, 2019 and 2027 (%)

10.3    Non-invasive Prenatal Testing (NIPT)

10.3.1     Overview

10.3.2     Noninvasive prenatal testing (NIPT): Liquid Biopsy Market – Revenue and Forecast to 2027 (US$ Million)

10.4    Oncology

10.4.1     Overview

10.4.2     Oncology: Liquid Biopsy Market – Revenue and Forecast to 2027 (US$ Million)

10.5    Transplant Diagnostics

10.5.1     Overview

10.5.2     Transplant Diagnostics: Liquid Biopsy Market – Revenue and Forecast to 2027 (US$ Million)

10.6    Other Applications

10.6.1     Overview

10.6.2     Other applications: Liquid Biopsy Market – Revenue and Forecast to 2027 (US$ Million)

11.          Liquid Biopsy Market Analysis – By End User

11.1    Overview

11.2    Liquid Biopsy Market, by End-User, 2019 and 2027 (%)

11.3    Academic & Research Institutes

11.3.1     Overview

11.3.2     Academic & Research Institutes: Liquid Biopsy Market – Revenue and Forecast to 2027 (US$ Million)

11.4    Hospitals

11.4.1     Overview

11.4.2     Hospitals: Liquid Biopsy Market – Revenue and Forecast to 2027 (US$ Million)

11.5    Reference Laboratories

11.5.1     Overview

11.6    Reference Laboratories: Liquid Biopsy Market – Revenue and Forecast to 2027 (US$ Million)

11.7    Other End Users

11.7.1     Overview

11.7.2     Other End Users: Liquid Biopsy Market – Revenue and Forecast to 2027 (US$ Million)

12.          Liquid Biopsy Market – Geographic Analysis

12.1    North America: Liquid Biopsy Market

12.1.1     Overview

12.1.2     North America: Liquid Biopsy Market – Revenue and Forecast to 2027 (USD Million)

12.1.3     North America: Liquid Biopsy Market, by Product & Service, 2018–2027 (USD Million)

12.1.4     North America: Liquid Biopsy Market, by Sample, 2018–2027 (USD Million)

12.1.5     North America: Liquid Biopsy Market, by Circulating Biomarker, 2018–2027 (USD Million)

12.1.6     North America: Liquid Biopsy Market, by Application, 2018–2027 (USD Million)

12.1.7     North America: Liquid Biopsy Market, by End User, 2018–2027 (USD Million)

12.1.8     North America: Liquid Biopsy Market, by Country, 2019 & 2027 (%)

12.1.9     US: Liquid Biopsy Market – Revenue and Forecast to 2027 (USD Million)

12.1.9.1    US: Liquid Biopsy Market – Revenue and Forecast to 2027 (USD Million)

12.1.9.2    US: Liquid Biopsy Market, by Product & Service, 2018–2027 (USD Million)

12.1.9.3    US: Liquid Biopsy Market, by Sample, 2018–2027 (USD Million)

12.1.9.4    US: Liquid Biopsy Market, by Circulating Biomarker, 2018–2027 (USD Million)

12.1.9.5    US: Liquid Biopsy Market, by Application, 2018–2027 (USD Million)

12.1.9.6    US: Liquid Biopsy Market, by End User, 2018–2027 (USD Million)

12.1.10   Canada: Liquid Biopsy Market – Revenue and Forecast to 2027 (USD Million)

12.1.10.1 Canada: Liquid Biopsy Market – Revenue and Forecast to 2027 (USD Million)

12.1.10.2 Canada: Liquid Biopsy Market, by Product & Service, 2018–2027 (USD Million)

12.1.10.3 Canada: Liquid Biopsy Market, by Sample, 2018–2027 (USD Million)

12.1.10.4 Canada: Liquid Biopsy Market, by Circulating Biomarker, 2018–2027 (USD Million)

12.1.10.5 Canada: Liquid Biopsy Market, by Application, 2018–2027 (USD Million)

12.1.10.6 Canada: Liquid Biopsy Market, by End User, 2018–2027 (USD Million)

12.1.11   Mexico: Liquid Biopsy Market – Revenue and Forecast to 2027 (USD Million)

12.1.11.1 Mexico: Liquid Biopsy Market – Revenue and Forecast to 2027 (USD Million)

12.1.11.2 Mexico: Liquid Biopsy Market, by Product & Service, 2018–2027 (USD Million)

12.1.11.3 Mexico: Liquid Biopsy Market, by Sample, 2018–2027 (USD Million)

12.1.11.4 Mexico: Liquid Biopsy Market, by Circulating Biomarker, 2018–2027 (USD Million)

12.1.11.5 Mexico: Liquid Biopsy Market, by Application, 2018–2027 (USD Million)

12.1.11.6 Mexico: Liquid Biopsy Market, by End User, 2018–2027 (USD Million)

12.2    Europe: Liquid Biopsy Market

12.2.1     Overview

12.2.2     Europe: Liquid Biopsy Market - Revenue and Forecast to 2027 (USD Million)

12.2.3     Europe: Liquid Biopsy Market, by Product & Service, 2018–2027 (USD Million)

12.2.4     Europe: Liquid Biopsy Market, by Sample, 2018–2027 (USD Million)

12.2.5     Europe: Liquid Biopsy Market, by Circulating Biomarker, 2018–2027 (USD Million)

12.2.6     Europe: Liquid Biopsy Market, by Application, 2018–2027 (USD Million)

12.2.7     Europe: Liquid Biopsy Market, by End User, 2018–2027 (USD Million)

12.2.8     Europe: Liquid Biopsy Market, by Country, 2018 & 2027 (%)

12.2.9     Germany: Liquid Biopsy Market – Revenue and Forecast to 2027 (USD Million)

12.2.9.1    Germany: Liquid Biopsy Market – Revenue and Forecast to 2027 (USD Million)

12.2.9.2    Germany: Liquid Biopsy Market, by Product & Service, 2018–2027 (USD Million)

12.2.9.3    Germany: Liquid Biopsy Market, by Sample, 2018–2027 (USD Million)

12.2.9.4    Germany: Liquid Biopsy Market, by Circulating Biomarker, 2018–2027 (USD Million)

12.2.9.5    Germany: Liquid Biopsy Market, by Application, 2018–2027 (USD Million)

12.2.9.6    Germany: Liquid Biopsy Market, by End User, 2018–2027 (USD Million)

12.2.10   UK: Liquid Biopsy Market – Revenue and Forecast to 2027 (USD Million)

12.2.10.1 UK: Liquid Biopsy Market – Revenue and Forecast to 2027 (USD Million)

12.2.10.2 UK: Liquid Biopsy Market, by Product & Service, 2018–2027 (USD Million)

12.2.10.3 UK: Liquid Biopsy Market, by Sample, 2018–2027 (USD Million)

12.2.10.4 UK: Liquid Biopsy Market, by Circulating Biomarker, 2018–2027 (USD Million)

12.2.10.5 UK: Liquid Biopsy Market, by Application, 2018–2027 (USD Million)

12.2.10.6 UK: Liquid Biopsy Market, by End User, 2018–2027 (USD Million)

12.2.11   France: Liquid Biopsy Market – Revenue and Forecast to 2027 (USD Million)

12.2.11.1 France: Liquid Biopsy Market – Revenue and Forecast to 2027 (USD Million)

12.2.11.2 France: Liquid Biopsy Market, by Product & Service, 2018–2027 (USD Million)

12.2.11.3 France: Liquid Biopsy Market, by Sample, 2018–2027 (USD Million)

12.2.11.4 France: Liquid Biopsy Market, by Circulating Biomarker, 2018–2027 (USD Million)

12.2.11.5 France: Liquid Biopsy Market, by Application, 2018–2027 (USD Million)

12.2.11.6 France: Liquid Biopsy Market, by End User, 2018–2027 (USD Million)

12.2.12   Spain: Liquid Biopsy Market – Revenue and Forecast to 2027 (USD Million)

12.2.12.1 Spain: Liquid Biopsy Market – Revenue and Forecast to 2027 (USD Million)

12.2.12.2 Spain: Liquid Biopsy Market, by Product & Service, 2018–2027 (USD Million)

12.2.12.3 Spain: Liquid Biopsy Market, by Sample, 2018–2027 (USD Million)

12.2.12.4 Spain: Liquid Biopsy Market, by Circulating Biomarker, 2018–2027 (USD Million)

12.2.12.5 Spain: Liquid Biopsy Market, by Application, 2018–2027 (USD Million)

12.2.12.6 Spain: Liquid Biopsy Market, by End User, 2018–2027 (USD Million)

12.2.13   Italy: Liquid Biopsy Market – Revenue and Forecast to 2027 (USD Million)

12.2.13.1 Italy: Liquid Biopsy Market – Revenue and Forecast to 2027 (USD Million)

12.2.13.2 Italy: Liquid Biopsy Market, by Product & Service, 2018–2027 (USD Million)

12.2.13.3 Italy: Liquid Biopsy Market, by Sample, 2018–2027 (USD Million)

12.2.13.4 Italy: Liquid Biopsy Market, by Circulating Biomarker, 2018–2027 (USD Million)

12.2.13.5 Italy: Liquid Biopsy Market, by Application, 2018–2027 (USD Million)

12.2.13.6 Italy: Liquid Biopsy Market, by End User, 2018–2027 (USD Million)

12.3    Asia Pacific: Liquid Biopsy Market

12.3.1     Overview

12.3.2     Asia Pacific: Liquid Biopsy Market - Revenue and Forecast to 2027 (USD Million)

12.3.3     Asia Pacific: Liquid Biopsy Market, by Product & Service, 2018–2027 (USD Million)

12.3.4     Asia Pacific: Liquid Biopsy Market, by Sample, 2018–2027 (USD Million)

12.3.5     Asia Pacific: Liquid Biopsy Market, by Circulating Biomarker, 2018–2027 (USD Million)

12.3.6     Asia Pacific: Liquid Biopsy Market, by Application, 2018–2027 (USD Million)

12.3.7     Asia Pacific: Liquid Biopsy Market, by End User, 2018–2027 (USD Million)

12.3.8     Asia Pacific: Liquid Biopsy Market, by Country, 2018 & 2027 (%)

12.3.9     China: Liquid Biopsy Market – Revenue and Forecast to 2027 (USD Million)

12.3.9.1    China: Liquid Biopsy Market – Revenue and Forecast to 2027 (USD Million)

12.3.9.2    China: Liquid Biopsy Market, by Product & Service, 2018–2027 (USD Million)

12.3.9.3    China: Liquid Biopsy Market, by Sample, 2018–2027 (USD Million)

12.3.9.4    China: Liquid Biopsy Market, by Circulating Biomarker, 2018–2027 (USD Million)

12.3.9.5    China: Liquid Biopsy Market, by Application, 2018–2027 (USD Million)

12.3.9.6    China: Liquid Biopsy Market, by End User, 2018–2027 (USD Million)

12.3.10   Japan: Liquid Biopsy Market – Revenue and Forecast to 2027 (USD Million)

12.3.10.1 Japan: Liquid Biopsy Market – Revenue and Forecast to 2027 (USD Million)

12.3.10.2 Japan: Liquid Biopsy Market, by Product & Service, 2018–2027 (USD Million)

12.3.10.3 Japan: Liquid Biopsy Market, by Sample, 2018–2027 (USD Million)

12.3.10.4 Japan: Liquid Biopsy Market, by Circulating Biomarker, 2018–2027 (USD Million)

12.3.10.5 Japan: Liquid Biopsy Market, by Application, 2018–2027 (USD Million)

12.3.10.6 Japan: Liquid Biopsy Market, by End User, 2018–2027 (USD Million)

12.3.11   India: Liquid Biopsy Market – Revenue and Forecast to 2027 (USD Million)

12.3.11.1 India: Liquid Biopsy Market – Revenue and Forecast to 2027 (USD Million)

12.3.11.2 India: Liquid Biopsy Market, by Product & Service, 2018–2027 (USD Million)

12.3.11.3 India: Liquid Biopsy Market, by Sample, 2018–2027 (USD Million)

12.3.11.4 India: Liquid Biopsy Market, by Circulating Biomarker, 2018–2027 (USD Million)

12.3.11.5 India: Liquid Biopsy Market, by Application, 2018–2027 (USD Million)

12.3.11.6 India: Liquid Biopsy Market, by End User, 2018–2027 (USD Million)

12.3.12   South Korea: Liquid Biopsy Market – Revenue and Forecast to 2027 (USD Million)

12.3.12.1 South Korea: Liquid Biopsy Market – Revenue and Forecast to 2027 (USD Million)

12.3.12.2 South Korea: Liquid Biopsy Market, by Product & Service, 2018–2027 (USD Million)

12.3.12.3 South Korea: Liquid Biopsy Market, by Sample, 2018–2027 (USD Million)

12.3.12.4 South Korea: Liquid Biopsy Market, by Circulating Biomarker, 2018–2027 (USD Million)

12.3.12.5 South Korea: Liquid Biopsy Market, by Application, 2018–2027 (USD Million)

12.3.12.6 South Korea: Liquid Biopsy Market, by End User, 2018–2027 (USD Million)

12.3.13   Australia: Liquid Biopsy Market – Revenue and Forecast to 2027 (USD Million)

12.3.13.1 Australia: Liquid Biopsy Market – Revenue and Forecast to 2027 (USD Million)

12.3.13.2 Australia: Liquid Biopsy Market, by Product & Service, 2018–2027 (USD Million)

12.3.13.3 Australia: Liquid Biopsy Market, by Sample, 2018–2027 (USD Million)

12.3.13.4 Australia: Liquid Biopsy Market, by Circulating Biomarker, 2018–2027 (USD Million)

12.3.13.5 Australia: Liquid Biopsy Market, by Application, 2018–2027 (USD Million)

12.3.13.6 Australia: Liquid Biopsy Market, by End User, 2018–2027 (USD Million)

12.4    Middle East & Africa: Liquid Biopsy Market

12.4.1     Overview

12.4.2     Middle East & Africa: Liquid Biopsy Market - Revenue and Forecast to 2027 (USD Million)

12.4.3     Middle East & Africa: Liquid Biopsy Market, by Product & Service, 2018–2027 (USD Million)

12.4.4     Middle East & Africa: Liquid Biopsy Market, by Sample, 2018–2027 (USD Million)

12.4.5     Middle East & Africa: Liquid Biopsy Market, by Circulating Biomarker, 2018–2027 (USD Million)

12.4.6     Middle East & Africa: Liquid Biopsy Market, by Application, 2018–2027 (USD Million)

12.4.7     Middle East & Africa: Liquid Biopsy Market, by End User, 2018–2027 (USD Million)

12.4.8     Middle East & Africa: Liquid Biopsy Market Share by Country – 2019 & 2027, (%)

12.4.9     Saudi Arabia: Liquid Biopsy Market – Revenue and Forecast to 2027 (USD Million)

12.4.9.1    Saudi Arabia: Liquid Biopsy Market – Revenue and Forecast to 2027 (USD Million)

12.4.9.2    Saudi Arabia: Liquid Biopsy Market, by Product & Service, 2018–2027 (USD Million)

12.4.9.3    Saudi Arabia: Liquid Biopsy Market, by Sample, 2018–2027 (USD Million)

12.4.9.4    Saudi Arabia: Liquid Biopsy Market, by Circulating Biomarker, 2018–2027 (USD Million)

12.4.9.5    Saudi Arabia: Liquid Biopsy Market, by Application, 2018–2027 (USD Million)

12.4.9.6    Saudi Arabia: Liquid Biopsy Market, by End User, 2018–2027 (USD Million)

12.4.10   UAE: Liquid Biopsy Market – Revenue and Forecast to 2027 (USD Million)

12.4.10.1 UAE: Liquid Biopsy Market – Revenue and Forecast to 2027 (USD Million)

12.4.10.2 UAE: Liquid Biopsy Market, by Product & Service, 2018–2027 (USD Million)

12.4.10.3 UAE: Liquid Biopsy Market, by Sample, 2018–2027 (USD Million)

12.4.10.4 UAE: Liquid Biopsy Market, by Circulating Biomarker, 2018–2027 (USD Million)

12.4.10.5 UAE: Liquid Biopsy Market, by Application, 2018–2027 (USD Million)

12.4.10.6 UAE: Liquid Biopsy Market, by End User, 2018–2027 (USD Million)

12.4.11   South Africa: Liquid Biopsy Market – Revenue and Forecast to 2027 (US$ Million)

12.4.11.1 South Africa: Liquid Biopsy Market – Revenue and Forecast to 2027 (USD Million)

12.4.11.2 South Africa: Liquid Biopsy Market, by Product & Service, 2018–2027 (USD Million)

12.4.11.3 South Africa: Liquid Biopsy Market, by Sample, 2018–2027 (USD Million)

12.4.11.4 South Africa: Liquid Biopsy Market, by Circulating Biomarker, 2018–2027 (USD Million)

12.4.11.5 South Africa: Liquid Biopsy Market, by Application, 2018–2027 (USD Million)

12.4.11.6 South Africa: Liquid Biopsy Market, by End User, 2018–2027 (USD Million)

12.5    South and Central America: Liquid Biopsy Market

12.5.1     Overview

12.5.2     South and Central America: Liquid Biopsy Market - Revenue and Forecast to 2027 (US$ Million)

12.5.3     South and Central America: Liquid Biopsy Market, by Product & Service, 2018–2027 (USD Million)

12.5.4     South and Central America: Liquid Biopsy Market, by Sample, 2018–2027 (USD Million)

12.5.5     South and Central America: Liquid Biopsy Market, by Circulating Biomarker, 2018–2027 (USD Million)

12.5.6     South and Central America: Liquid Biopsy Market, by Application, 2018–2027 (USD Million)

12.5.7     South and Central America: Liquid Biopsy Market, by End User, 2018–2027 (USD Million)

12.5.8     South and Central America: Liquid Biopsy Market, by Country, 2018 & 2027 (%)

12.5.9     Brazil: Liquid Biopsy Market – Revenue and Forecast to 2027 (USD Million)

12.5.9.1    Brazil: Liquid Biopsy Market – Revenue and Forecast to 2027 (USD Million)

12.5.9.2    Brazil: Liquid Biopsy Market, by Product & Service, 2018–2027 (USD Million)

12.5.9.3    Brazil: Liquid Biopsy Market, by Sample, 2018–2027 (USD Million)

12.5.9.4    Brazil: Liquid Biopsy Market, by Circulating Biomarker, 2018–2027 (USD Million)

12.5.9.5    Brazil: Liquid Biopsy Market, by Application, 2018–2027 (USD Million)

12.5.9.6    Brazil: Liquid Biopsy Market, by End User, 2018–2027 (USD Million)

12.5.10   Argentina: Liquid Biopsy Market – Revenue and Forecast to 2027 (USD Million)

12.5.10.1 Argentina: Liquid Biopsy Market – Revenue and Forecast to 2027 (USD Million)

12.5.10.2 Argentina: Liquid Biopsy Market, by Product & Service, 2018–2027 (USD Million)

12.5.10.3 Argentina: Liquid Biopsy Market, by Sample, 2018–2027 (USD Million)

12.5.10.4 Argentina: Liquid Biopsy Market, by Circulating Biomarker, 2018–2027 (USD Million)

12.5.10.5 Argentina: Liquid Biopsy Market, by Application, 2018–2027 (USD Million)

12.5.10.6 Argentina: Liquid Biopsy Market, by End User, 2018–2027 (USD Million)

13.          Impact Of COVID-19 Pandemic On Global Liquid Biopsy Market

13.1    North America: Impact Assessment of COVID-19 Pandemic

13.2    Europe: Impact Assessment Of COVID-19 Pandemic

13.3    Asia-Pacific: Impact Assessment of COVID-19 Pandemic

13.4    Rest of the World: Impact Assessment of COVID-19 Pandemic

14.          Liquid Biopsy Market –Industry Landscape

14.1    Overview

14.2    Growth Strategies in The Liquid Biopsy Market, 2016-2020

14.3    Inorganic Growth Strategies

14.3.1     Overview

14.4    Organic Growth Strategies

14.4.1     Overview

15.          Liquid Biopsy Market, Key Company Profiles

15.1    Thermo Fisher Scientific Inc.

15.1.1     Key Facts

15.1.2     Business Description

15.1.3     Products and Services

15.1.4     Financial Overview

15.1.5     SWOT Analysis

15.1.6     Key Developments

15.2    F. Hoffmann-la Roche ltd

15.2.1     Key Facts

15.2.2     Business Description

15.2.3     Products and Services

15.2.4     Financial Overview

15.2.5     SWOT Analysis

15.2.6     Key Developments

15.3    Bio-Rad Laboratories Inc.

15.3.1     Key Facts

15.3.2     Business Description

15.3.3     Products and Services

15.3.4     Financial Overview

15.3.5     SWOT Analysis

15.3.6     Key Developments

15.4    Qiagen

15.4.1     Key Facts

15.4.2     Business Description

15.4.3     Products and Services

15.4.4     Financial Overview

15.4.5     SWOT Analysis

15.4.6     Key Developments

15.5    Exact Sciences Corporation

15.5.1     Key Facts

15.5.2     Business Description

15.5.3     Products and Services

15.5.4     Financial Overview

15.5.5     SWOT Analysis

15.5.6     ey Developments

15.6    Biocept, Inc.

15.6.1     Key Facts

15.6.2     Business Description

15.6.3     Products and Services

15.6.4     Financial Overview

15.6.5     SWOT Analysis

15.6.6     Key Developments

15.7    Inivata Ltd

15.7.1     Key Facts

15.7.2     Business Description

15.7.3     Products and Services

15.7.4     Financial Overview

15.7.5     SWOT Analysis

15.7.6     Key Developments

15.8    LungLife AI, Inc.

15.8.1     Key Facts

15.8.2     Business Description

15.8.3     Products and Services

15.8.4     Financial Overview

15.8.5     SWOT Analysis

15.8.6     Key Developments

15.9    Exosome Diagnostics

15.9.1     Key Facts

15.9.2     Business Description

15.9.3     Products and Services

15.9.4     Financial Overview

15.9.5     SWOT Analysis

15.9.6     Key Developments

15.10 MDxHealth

15.10.1   Key Facts

15.10.2   Business Description

15.10.3   Products and Services

15.10.4   Financial Overview

15.10.5   SWOT Analysis

15.10.6   Key Developments

16.          Appendix

16.1    About the Insight Partners

16.2    Glossary of Terms

LIST OF TABLES

Table 1.             North America Liquid Biopsy Market, by Product & Service– Revenue and Forecast to 2027 (USD Million)

Table 2.             North America Liquid Biopsy Market, by Sample – Revenue and Forecast to 2027 (USD Million)

Table 3.             North America Liquid Biopsy Market, by Circulating Biomarker – Revenue and Forecast to 2027 (USD Million)

Table 4.             North America Liquid Biopsy Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 5.             North America Liquid Biopsy Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 6.             Estimated Number of New Cancer Cases and Deaths, US, 2020

Table 7.             US Liquid Biopsy Market, by Product & Service – Revenue and Forecast to 2027 (USD Million)

Table 8.             US Liquid Biopsy Market, by Sample – Revenue and Forecast to 2027 (USD Million)

Table 9.             US Liquid Biopsy Market, by Circulating Biomarker – Revenue and Forecast to 2027 (USD Million)

Table 10.          US Liquid Biopsy Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 11.          US Liquid Biopsy Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 12.          Canada Liquid Biopsy Market, by Product & Service – Revenue and Forecast to 2027 (USD Million)

Table 13.          Canada Liquid Biopsy Market, by Sample – Revenue and Forecast to 2027 (USD Million)

Table 14.          Canada Liquid Biopsy Market, by Circulating Biomarker – Revenue and Forecast to 2027 (USD Million)

Table 15.          Canada Liquid Biopsy Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 16.          Canada Liquid Biopsy Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 17.          Mexico Incidence, Mortality and Prevalence by cancer site in 2018

Table 18.          Mexico Liquid Biopsy Market, by Product & Service – Revenue and Forecast to 2027 (USD Million)

Table 19.          Mexico Liquid Biopsy Market, by Sample – Revenue and Forecast to 2027 (USD Million)

Table 20.          Mexico Liquid Biopsy Market, by Circulating Biomarker – Revenue and Forecast to 2027 (USD Million)

Table 21.          Mexico Liquid Biopsy Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 22.          Mexico Liquid Biopsy Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 23.          Europe Liquid Biopsy Market, by Product & Service– Revenue and Forecast to 2027 (USD Million)

Table 24.          Europe Liquid Biopsy Market, by Sample – Revenue and Forecast to 2027 (USD Million)

Table 25.          Europe Liquid Biopsy Market, by Circulating Biomarker – Revenue and Forecast to 2027 (USD Million)

Table 26.          Europe Liquid Biopsy Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 27.          Europe Liquid Biopsy Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 28.          Incidence, Mortality and Prevalence by cancer site, 2018, Germany

Table 29.          Germany Liquid Biopsy Market, by Product & Service – Revenue and Forecast to 2027 (USD Million)

Table 30.          Germany Liquid Biopsy Market, by Sample – Revenue and Forecast to 2027 (USD Million)

Table 31.          Germany Liquid Biopsy Market, by Circulating Biomarker – Revenue and Forecast to 2027 (USD Million)

Table 32.          Germany Liquid Biopsy Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 33.          Germany Liquid Biopsy Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 34.          UK Liquid Biopsy Market, by Product & Service – Revenue and Forecast to 2027 (USD Million)

Table 35.          UK Liquid Biopsy Market, by Sample – Revenue and Forecast to 2027 (USD Million)

Table 36.          UK Liquid Biopsy Market, by Circulating Biomarker – Revenue and Forecast to 2027 (USD Million)

Table 37.          UK Liquid Biopsy Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 38.          UK Liquid Biopsy Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 39.          Incidence, Mortality and Prevalence By Cancer Site, 2018, France

Table 40.          France Liquid Biopsy Market, by Product & Service – Revenue and Forecast to 2027 (USD Million)

Table 41.          France Liquid Biopsy Market, by Sample – Revenue and Forecast to 2027 (USD Million)

Table 42.          France Liquid Biopsy Market, by Circulating Biomarker – Revenue and Forecast to 2027 (USD Million)

Table 43.          France Liquid Biopsy Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 44.          France Liquid Biopsy Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 45.          Incidence, Mortality and Prevalence By Cancer Site, 2018, Spain

Table 46.          Spain Liquid Biopsy Market, by Product & Service – Revenue and Forecast to 2027 (USD Million)

Table 47.          Spain Liquid Biopsy Market, by Sample – Revenue and Forecast to 2027 (USD Million)

Table 48.          Spain Liquid Biopsy Market, by Circulating Biomarker – Revenue and Forecast to 2027 (USD Million)

Table 49.          Spain Liquid Biopsy Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 50.          Spain Liquid Biopsy Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 51.          Incidence, Mortality and Prevalence by cancer site, 2018, Italy

Table 52.          Italy Liquid Biopsy Market, by Product & Service – Revenue and Forecast to 2027 (USD Million)

Table 53.          Italy Liquid Biopsy Market, by Sample – Revenue and Forecast to 2027 (USD Million)

Table 54.          Italy Liquid Biopsy Market, by Circulating Biomarker – Revenue and Forecast to 2027 (USD Million)

Table 55.          Italy Liquid Biopsy Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 56.          Italy Liquid Biopsy Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 57.          Asia Pacific Liquid Biopsy Market, by Product & Service– Revenue and Forecast to 2027 (USD Million)

Table 58.          Asia Pacific Liquid Biopsy Market, by Sample – Revenue and Forecast to 2027 (USD Million)

Table 59.          Asia Pacific Liquid Biopsy Market, by Circulating Biomarker – Revenue and Forecast to 2027 (USD Million)

Table 60.          Asia Pacific Liquid Biopsy Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 61.          Asia Pacific Liquid Biopsy Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 62.          China Liquid Biopsy Market, by Product & Service – Revenue and Forecast to 2027 (USD Million)

Table 63.          China Liquid Biopsy Market, by Sample – Revenue and Forecast to 2027 (USD Million)

Table 64.          China Liquid Biopsy Market, by Circulating Biomarker – Revenue and Forecast to 2027 (USD Million)

Table 65.          China Liquid Biopsy Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 66.          China Liquid Biopsy Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 67.          Japan Liquid Biopsy Market, by Product & Service – Revenue and Forecast to 2027 (USD Million)

Table 68.          Japan Liquid Biopsy Market, by Sample – Revenue and Forecast to 2027 (USD Million)

Table 69.          Japan Liquid Biopsy Market, by Circulating Biomarker – Revenue and Forecast to 2027 (USD Million)

Table 70.          Japan Liquid Biopsy Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 71.          Japan Liquid Biopsy Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 72.          India Liquid Biopsy Market, by Product & Service – Revenue and Forecast to 2027 (USD Million)

Table 73.          India Liquid Biopsy Market, by Sample – Revenue and Forecast to 2027 (USD Million)

Table 74.          India Liquid Biopsy Market, by Circulating Biomarker – Revenue and Forecast to 2027 (USD Million)

Table 75.          India Liquid Biopsy Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 76.          India Liquid Biopsy Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 77.          South Korea Liquid Biopsy Market, by Product & Service – Revenue and Forecast to 2027 (USD Million)

Table 78.          South Korea Liquid Biopsy Market, by Sample – Revenue and Forecast to 2027 (USD Million)

Table 79.          South Korea Liquid Biopsy Market, by Circulating Biomarker – Revenue and Forecast to 2027 (USD Million)

Table 80.          South Korea Liquid Biopsy Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 81.          South Korea Liquid Biopsy Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 82.          Incidence, Mortality and Prevalence by cancer site, Australia, 2018

Table 83.          Australia Liquid Biopsy Market, by Product & Service – Revenue and Forecast to 2027 (USD Million)

Table 84.          Australia Liquid Biopsy Market, by Sample – Revenue and Forecast to 2027 (USD Million)

Table 85.          Australia Liquid Biopsy Market, by Circulating Biomarker – Revenue and Forecast to 2027 (USD Million)

Table 86.          Australia Liquid Biopsy Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 87.          Australia Liquid Biopsy Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 88.          Middle East & Africa Liquid Biopsy Market, by Product & Service– Revenue and Forecast to 2027 (USD Million)

Table 89.          Middle East & Africa Liquid Biopsy Market, by Sample – Revenue and Forecast to 2027 (USD Million)

Table 90.          Middle East & Africa Liquid Biopsy Market, by Circulating Biomarker – Revenue and Forecast to 2027  (USD Million)

Table 91.          Middle East & Africa Liquid Biopsy Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 92.          Middle East & Africa Liquid Biopsy Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 93.          Saudi Arabia Liquid Biopsy Market, by Product & Service – Revenue and Forecast to 2027 (USD Million)

Table 94.          Saudi Arabia Liquid Biopsy Market, by Sample – Revenue and Forecast to 2027 (USD Million)

Table 95.          Saudi Arabia Liquid Biopsy Market, by Circulating Biomarker – Revenue and Forecast to 2027 (USD Million)

Table 96.          Saudi Arabia Liquid Biopsy Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 97.          Saudi Arabia Liquid Biopsy Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 98.          UAE Liquid Biopsy Market, by Product & Service – Revenue and Forecast to 2027 (USD Million)

Table 99.          UAE Liquid Biopsy Market, by Sample – Revenue and Forecast to 2027 (USD Million)

Table 100.       UAE Liquid Biopsy Market, by Circulating Biomarker – Revenue and Forecast to 2027 (USD Million)

Table 101.       UAE Liquid Biopsy Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 102.       UAE Liquid Biopsy Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 103.       South Africa Liquid Biopsy Market, by Product & Service – Revenue and Forecast to 2027 (USD Million)

Table 104.       South Africa Liquid Biopsy Market, by Sample – Revenue and Forecast to 2027 (USD Million)

Table 105.       South Africa Liquid Biopsy Market, by Circulating Biomarker – Revenue and Forecast to 2027 (USD Million)

Table 106.       South Africa Liquid Biopsy Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 107.       South Africa Liquid Biopsy Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 108.       South and Central America Liquid Biopsy Market, by Product & Service– Revenue and Forecast to 2027 (USD Million)

Table 109.       South and Central America Liquid Biopsy Market, by Sample – Revenue and Forecast to 2027 (USD Million)

Table 110.       South and Central America Liquid Biopsy Market, by Circulating Biomarker – Revenue and Forecast to 2027 (USD Million)

Table 111.       South and Central America Liquid Biopsy Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 112.       South and Central America Liquid Biopsy Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 113.       Brazil Liquid Biopsy Market, by Product & Service – Revenue and Forecast to 2027 (USD Million)

Table 114.       Brazil Liquid Biopsy Market, by Sample – Revenue and Forecast to 2027 (USD Million)

Table 115.       Brazil Liquid Biopsy Market, by Circulating Biomarker – Revenue and Forecast to 2027 (USD Million)

Table 116.       Brazil Liquid Biopsy Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 117.       Brazil Liquid Biopsy Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 118.       Argentina Liquid Biopsy Market, by Product & Service – Revenue and Forecast to 2027 (USD Million)

Table 119.       Argentina Liquid Biopsy Market, by Sample – Revenue and Forecast to 2027 (USD Million)

Table 120.       Argentina Liquid Biopsy Market, by Circulating Biomarker – Revenue and Forecast to 2027 (USD Million)

Table 121.       Argentina Liquid Biopsy Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 122.       Argentina Liquid Biopsy Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 123.       Recent Inorganic Growth Strategies inthe liquid biopsy Market

Table 124.       Recent Organic Growth StrategiesIn The Liquid Biopsy Market

Table 125.       Glossary of Terms, Liquid Biopsy Market

 

 

LIST OF FIGURES

Figure 1.           Liquid Biopsy Market Segmentation

Figure 2.           Liquid Biopsy Segmentation, By Region

Figure 3.           Global Liquid Biopsy Market Overview

Figure 4.           Reagents & Kits Segment Held Largest Share Of Product & Services Segment In Liquid Biopsy Market

Figure 5.           Asia-Pacific Region Is Expected to Show Remarkable Growth During the Forecast Period

Figure 6.           Global Liquid Biopsy Market, By Geography (US$ Million)

Figure 7.           Global Liquid Biopsy Market- Leading Country Markets (US$ Million)

Figure 8.           Global Liquid Biopsy Market, Industry Landscape

Figure 9.           North America PEST Analysis

Figure 10.        Europe PEST Analysis

Figure 11.        Asia Pacific PEST Analysis

Figure 12.        Middle East and Africa (MEA) PEST Analysis

Figure 13.        South and Central America PEST Analysis

Figure 14.        Liquid Biopsy Market Impact Analysis Of Driver And Restraints

Figure 15.        Global Liquid Biopsy Market – Revenue Forecast and Analysis – 2019- 2027

Figure 16.        Global Liquid biopsy Market – By Geography Forecast And Analysis – 2019- 2027

Figure 17.        Market Positioning Of Key Players In Global Liquid biopsy Market

Figure 18.        Liquid Biopsy Market Revenue Share, by Product & Service (2019 and 2027)

Figure 19.        Equipment :Liquid Biopsy Market – Revenue and Forecast to 2027 (US$ Million)

Figure 20.        Reagents & Kits: Liquid Biopsy Market – Revenue and Forecast to 2027 (US$ Million)

Figure 21.        Services: Liquid Biopsy Market – Revenue and Forecast to 2027 (US$ Million)

Figure 22.        Liquid Biopsy Market, by Sample, 2019 and 2027 (%)

Figure 23.        Blood Based: Liquid Biopsy Market – Revenue and Forecast to 2027 (US$ Million)

Figure 24.        Urine Based: Liquid Biopsy Market – Revenue and Forecast to 2027 (US$ Million)

Figure 25.        Other Samples: Liquid Biopsy Market – Revenue and Forecast to 2027 (US$ Million)

Figure 26.        Liquid Biopsy Market, by Circulating Biomarker, 2019 and 2027 (%)

Figure 27.        Circulating Tumor Cell (CTC): Liquid Biopsy Market – Revenue and Forecast to 2027 (US$ Million)

Figure 28.        Exosomes: Liquid Biopsy Market – Revenue and Forecast to 2027 (US$ Million)

Figure 29.        Free Nucleic Acid: Liquid Biopsy Market – Revenue and Forecast to 2027 (US$ Million)

Figure 30.        Liquid Biopsy Market, by Application, 2019 and 2027 (%)

Figure 31.        Noninvasive prenatal testing (NIPT): Liquid Biopsy Market – Revenue and Forecast to 2027 (US$ Million)

Figure 32.        Oncology: Liquid Biopsy Market – Revenue and Forecast to 2027 (US$ Million)

Figure 33.        Transplant Diagnostics: Liquid Biopsy Market – Revenue and Forecast to 2027 (US$ Million)

Figure 34.        Other applications: Liquid Biopsy Market – Revenue and Forecast to 2027 (US$ Million)

Figure 35.        Liquid Biopsy Market, by End-User, 2019 and 2027 (%)

Figure 36.        Academic & Research Institutes: Liquid Biopsy Market – Revenue and Forecast to 2027 (US$ Million)

Figure 37.        Hospitals: Liquid Biopsy Market – Revenue and Forecast to 2027 (US$ Million)

Figure 38.        Reference Laboratories: Liquid Biopsy Market – Revenue and Forecast to 2027 (US$ Million)

Figure 39.        Other End Users: Liquid Biopsy Market – Revenue and Forecast to 2027 (US$ Million)

Figure 40.        North America: Liquid Biopsy Market, by Key Country – Revenue (2019) (USD Million)

Figure 41.        North America Liquid Biopsy Market Revenue and Forecast to 2027 (USD Million)

Figure 42.        North America: Liquid Biopsy Market, by Country, 2019 & 2027 (%)

Figure 43.        US: Liquid Biopsy Market – Revenue and Forecast to 2027 (USD Million)

Figure 44.        Canada: Liquid Biopsy Market – Revenue and Forecast to 2027 (USD Million)

Figure 45.        Mexico: Liquid Biopsy Market – Revenue and Forecast to 2027 (USD Million)

Figure 46.        Europe: Liquid Biopsy Market, by Key Country – Revenue (2019) (USD Million)

Figure 47.        Europe Liquid Biopsy Market Revenue and Forecast to 2027 (USD Million)

Figure 48.        Europe: Liquid Biopsy Market, by Country, 2018 & 2027 (%)

Figure 49.        Germany: Liquid Biopsy Market – Revenue and Forecast to 2027 (USD Million)

Figure 50.        UK: Liquid Biopsy Market – Revenue and Forecast to 2027 (USD Million)

Figure 51.        France: Liquid Biopsy Market – Revenue and Forecast to 2027 (USD Million)

Figure 52.        Spain: Liquid Biopsy Market – Revenue and Forecast to 2027 (USD Million)

Figure 53.        Italy: Liquid Biopsy Market – Revenue and Forecast to 2027 (USD Million)

Figure 54.        Asia Pacific: Liquid Biopsy Market, by Key Country – Revenue (2019) (USD Million)

Figure 55.        Asia Pacific Liquid Biopsy Market Revenue and Forecast to 2027 (USD Million)

Figure 56.        China: Liquid Biopsy Market – Revenue and Forecast to 2027 (USD Million)

Figure 57.        Japan: Liquid Biopsy Market – Revenue and Forecast to 2027 (USD Million)

Figure 58.        India: Liquid Biopsy Market – Revenue and Forecast to 2027 (USD Million)

Figure 59.        South Korea: Liquid Biopsy Market – Revenue and Forecast to 2027 (USD Million)

Figure 60.        Australia: Liquid Biopsy Market – Revenue and Forecast to 2027 (USD Million)

Figure 61.        Middle East & Africa: Liquid Biopsy Market, by Key Country – Revenue (2019) (USD Million)

Figure 62.        Middle East & Africa Liquid Biopsy Market Revenue and Forecast to 2027 (USD Million)

Figure 63.        Middle East & Africa: Liquid Biopsy Market Share by Country – 2019 & 2027, (%)

Figure 64.        Saudi Arabia: Liquid Biopsy Market – Revenue and Forecast to 2027 (USD Million)

Figure 65.        UAE: Liquid Biopsy Market – Revenue and Forecast to 2027 (US$ Million)

Figure 66.        South Africa: Liquid Biopsy Market – Revenue and Forecast to 2027 (USD Million)

Figure 67.        South and Central America: Liquid Biopsy Market, by Key Country – Revenue (2019) (USD Million)

Figure 68.        South and Central America Liquid Biopsy Market Revenue and Forecast to 2027 (USD Million)

Figure 69.        South and Central America: Liquid Biopsy Market, by Country, 2018 & 2027 (%)

Figure 70.        Brazil: Liquid Biopsy Market – Revenue and Forecast to 2027 (USD Million)

Figure 71.        Argentina: Liquid Biopsy Market – Revenue and Forecast to 2027 (USD Million)

Figure 72.        Impact of COVID-19 Pandemic In North American Country Markets

Figure 73.        Impact of COVID-19 Pandemic In European Country Markets

Figure 74.        Impact of COVID-19 Pandemic In Asia Pacific Country Markets

Figure 75.        Impact Of COVID-19 Pandemic In Rest of the World Countries Market

Figure 76.        Growth Strategies in TheLiquid Biopsy Market, 2016-2020

 

The List of Companies - Liquid Biopsy Market

  1. Biocept, Inc
  2. Bio-Rad Laboratories Inc
  3. LungLife AI, Inc
  4. Exosome Diagnostics
  5. F. Hoffmann-la Roche ltd
  6. Exact Sciences Corporation
  7. Inivata Ltd
  8. MDxHealth
  9. Qiagen
  10. Thermo Fisher Scientific Inc.
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the liquid biopsy market.

 

  • Highlights key business priorities in order to assist companies to realign their business strategies.

 

  • The key findings and recommendations highlight crucial progressive industry trends in the global breast cancer screening market, thereby allowing players across the value chain to develop effective long-term strategies.

 

  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

 

  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

 

  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

 

TIPRE00003996
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Frequently Asked Questions

Liquid biopsy is a revolutionary technology that is opening up various perspectives. The technology consists of isolation and detection of circulating tumor cells, circulating tumor DNA and exosomes, which provides genomic information of the cancer patients. Liquid biopsy are used in cancer diagnosis in order to study response or resistance to given treatments.

The growth of the market is attributed to some key driving factors such as increasing prevalence of cancer and growing geriatric population. However, low sensitivity of liquid biopsy is likely to pose a negative impact on the market during the forecast years.

The North American region holds the largest market for the liquid biopsy. The United States held the largest market for liquid biopsy mean market and is expected to grow due to factors such as Increasing incidence of cancer, growing need for diagnosing cancer, increasing competition between the market player, high R&D spending, and government grants for research institutes to develop new diagnostics.

Pricing